⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12317971 | 0.79 | — | — | |
| SCHEMBL24799358 | 0.70 | — | — | |
| SCHEMBL13364404 | 0.63 | MT-CO2 (0.30) | — | |
| SCHEMBL22140646 | 0.60 | — | — | |
| SCHEMBL13883985 | 0.60 | — | — | |
| SCHEMBL2690835 | 0.58 | KDM4E (0.42) | — | |
| SCHEMBL13107416 | 0.58 | SIGMAR1 (0.31) | — | |
| SCHEMBL15043693 | 0.56 | LIPA (0.38) | — | |
| SCHEMBL14576723 | 0.56 | LIPA (0.38) | — | |
| SCHEMBL526891 | 0.56 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010056827-A1 | BETA-LACTAMASE INHIBITORS | PROTEZ PHARMACEUTICALS, INC. (US) | 2010-05-20 | — | — | WO | disclosed |
| WO-2009064414-A1 | BETA-LACTAMASE INHIBITORS | PROTEZ PHARMACEUTICALS, INC. (US) | 2009-05-22 | — | — | WO | disclosed |